Adipose-derived stem cells (ADSCs) have recently been considered as a promising therapy for erectile dysfunction (ED). However, the mechanism of ADSC-based therapy is unclear. Insulin-like growth factor-1 (IGF-1), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) secreted by ADSCs were assessed in vitro. Sixteen 24-month-old male Sprague-Dawley rats were used for comparative analysis of 2-week treatment with labeled ADSCs or PBS. Eight additional 5-month-old rats were used as a young rat group. At 2 weeks post-transplantation, all rats were analyzed for erectile function, cavernous IGF-1, bFGF and VEGF levels, and penile histology. Conditioned medium and co-culture systems were used in cell experiments to detect how growth factors act on corpus cavernosum smooth muscle cells (CCSMCs) under oxidative stress conditions via crystal violet staining and immunofluorescence staining. We found that ADSCs secreted significantly higher IGF-1, bFGF, and VEGF levels in culture medium compared with basal medium. Compared with young rats, untreated aged rats had significantly lower Max ICP/MAP and ADSC treatment significantly increased the ratio. Immunofluorescence staining demonstrated a small number of labeled ADSCs in the corpus cavernosum. The untreated aged rats showed significantly decreased cavernous IGF-1, bFGF, and VEGF levels and significantly decreased contents of cavernous smooth muscle and endothelium compared with young rats. ADSC treatment partially normalized these alterations. In cell experiments, the groups receiving growth factor neutralizing antibody separately or combined had significantly decreased numbers of CCSMCs compared with control groups. These results indicated that ADSC treatment may improve aging-related ED partially through the secretion of IGF-1, bFGF, and VEGF.
INTRODUCTION
Erectile dysfunction (ED) is a prevailing health problem that compromises the quality of life of men and their partners (Shamloul & Ghanem, 2013) . It was reported that aging is an independent predictor of ED, irrespective of comorbid diseases . The Massachusetts Male Aging Study demonstrated that the annual incidence rate of ED was 1.2% in men aged between 40 and 49 years and the rate increased to 4.6% in men aged between 60 and 69 years (Johannes et al., 2000) . The molecular pathophysiology of aging-related erectile dysfunction is complex but involves endothelial dysfunction, increased vasoconstriction, oxidative stress, and veno-occlusive dysfunction (Ferrini et al., 2017) .
Recently, the intracavernous injection of stem cells has emerged as one of the most promising therapies for ED in preclinical animal studies and clinical trials. The transplantation of adult stem cells, especially bone marrow-derived stem cells (BMSCs) and skeletal muscle-derived stem cells (MDSCs), improved erectile function in aged rats (Bivalacqua et al., 2007; Nolazco et al., 2008; Abdel et al., 2010) . However, BMSCs and MDSCs transplantation requires a large amount of bone marrow and skeletal muscle, respectively, obtained under general anesthesia, which is invasive and may impose a heavy load on patients.
Adipose-derived stem cells (ADSCs), another type of adult stem cell, have attracted attention because they are relatively easy to isolate and culture. Many studies showed that ADSCs possess the ability to differentiate into a variety of cell phenotypes, including adipocytes, osteocytes, smooth muscle cells, and endothelial cells (Gimble et al., 2007) . ADSCs were reported to secrete potent combinations of trophic factors including vascular endothelial growth factor (VEGF), insulin-like growth factor-1 (IGF-1), and basic fibroblast growth factor (bFGF) related to paracrine actions (Baraniak & McDevitt, 2010; Hoke et al., 2012) . The effectiveness of the intracavernous injection of ADSCs was evaluated in rats with diabetes, cavernous injury, and hyperlipidemia, and the results showed that erectile function had been restored. Although the administration of ADSCs on aged-ED has not been reported, BMSCs have been shown to have benefits on penile rehabilitation , which is thought to have similar cell property and multilineage potential with ADSCs; thus, we assumed that ADSCs could ameliorate erectile function of aged rats, and the mechanisms of the improved effect were what we focused on in this study.
Many studies speculated that growth factors and cytokines secreted by stem cells are responsible for improved erectile function (Garcia et al., 2010; Hakim et al., 2012; Nishimatsu et al., 2012; Sun et al., 2012) . It was reported that IGF-1 and VEGF secreted by stem cells were associated with their therapeutic benefit in the nervous system and heart (Baraniak & McDevitt, 2010) . bFGF also has a cardioprotective role in ischemic oxidative damage (Wang et al., 2015) . Furthermore, IGF-1, bFGF, and VEGF are important mediators in the physiology of erectile function. The expression of IGF-1 and VEGF was dramatically decreased in the penile tissues of aged rats, and IGF-1 or VEGF treatment reversed aging-associated ED (Park et al., 2004; Pu et al., 2007) . bFGF treatment also improved erectile function in a rat model of cavernous nerve injury (Bae et al., 2014) . A basic study found that growth factors including IGF-1, bFGF, and VEGF improved cell function under oxidative stress conditions (Hao & Rockwell, 2013; Chen et al., 2014; Nawrocka et al., 2017) . However, whether the secretion of IGF-1, bFGF, and VEGF by ADSCs is in part responsible for enhancing erectile function in aged rats has not been investigated.
Therefore, this study investigated whether the transplantation of ADSCs resolved aging-related ED and its underlying mechanisms.
MATERIAL AND METHODS

Isolation and identification of ADSCs
ADSCs were cultured from male Sprague-Dawley (SD) rats as previously described . Briefly, inguinal adipose tissues isolated from rats were minced into small fragments and then were incubated with 0.075% collagenase type I (Sigma-Aldrich, St. Louis, MO, USA) for 90 min at 37°C with vigorous shaking for 20 sec at 15-min interval. After centrifugation at 1000 g for 10 min, the top lipid layer was removed. The pellet was treated with red blood cell (RBC) lysis buffer for 10 min on ice to lyse RBCs. Subsequently, the remaining cells were plated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1% streptomycin, 1% penicillin, and 10% fetal bovine serum (FBS) and filtrated through a 75-lm cell strainer. The culture dish was maintained in a 5% CO 2 incubator at 37°C.
Passage 4 ADSCs were used to analyze the cell phenotype by flow cytometry. Approximately 1 9 10 5 cells were incubated with antibodies against rat CD29, CD90, CD31, CD34, CD45, and CD106 (BD Biosciences, San Diego, CA, USA) for 30 min at 4°C in the dark. To confirm the multipotency of ADSCs, the induction of adipocytes and osteoblasts was performed with adipogenic medium (DMEM containing 10% FBS, 0.5 mmol/L isobutylmethylxanthine, 200 lmol/L indomethacin, 10 lmol/L bovine insulin, and 1 lmol/L dexamethasone) and osteogenic medium (DMEM containing 10% FBS, 10 mmol/L b-glycerophosphate, 0.1 lmol/L dexamethasone, and 50 lmol/L ascorbic acid), respectively (all the reagents were purchased from Sigma) .
Animals and study design
Sixteen 24-month-old male Sprague-Dawley rats were used as aged rats, which were randomly divided into two groups (untreated aged rats group and ADSC-treated aged rats group, n = 8/group). Eight 5-month-old rats were used as the young rat group. All procedures involving animals were carried out in accordance with the guidelines by the Chinese Council on Animal Care and with approval from the Committees on Animal Experiments at Tongji Hospital (Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China).
CM-DiI labeling and intracavernous injection of ASDCs
Passage 4 ADSCs were labeled with CM-DiI (5 lmol/mL; Molecular Probes, Carlsbad, CA, USA) according to the manufacturer's instructions for tracking cells in vivo. Briefly, ADSCs were incubated in 10% FBS-supplemented DMEM medium containing 5 lmol/mL CM-DiI for 5 min at 37°C, and then for an additional 15 min at 4°C. After labeling, the cells were washed with phosphate-buffered saline (PBS) three times, and then a total of 5 9 10 5 CM-DiI-labeled ADSCs were collected into a 2-mL conical tube containing 200 lL PBS and prepared for intracavernous injection. All rats were anesthetized by an intraperitoneal injection of pentobarbital sodium (35 mg/kg). Before the intracavernous injection of ADSCs, the penile base was constricted with an elastic band. Then, 200 lL PBS solution containing 5 9 10 5 CM-DiI-labeled ADSCs was injected into the corpora cavernosum in the treatment group rats with a 27-G needle, while the aged control rats and young control rats received an equal volume of PBS vehicle. The elastic band was removed 5 min after the injection.
Evaluation of erectile function
After 2 weeks of treatment, erectile function was assessed in three groups according to our previous studies Yang et al., 2013) . Briefly, the rats were anesthetized with pentobarbital sodium and the left carotid artery was cannulated with PE-50 tubing to measure the mean systemic artery pressure (SAP). The cavernous nerve was isolated, and a 25-gauge needle was inserted into the right crus to evaluate intracavernosal pressure (ICP). The pressure results were recorded using the data acquisition system (ADInstruments Powerlab/4SP, NSW 2153, Australia). Erectile response was induced by electrical stimulation of the cavernous nerve at 15 Hz frequency for 1 min and was measured at several voltages (2.5, 5.0, and 7.5 V).
After the functional evaluation, the rats were euthanized by an intraperitoneal overdose of pentobarbital sodium. The middle regions of the skin-denuded penile shaft were embedded in optimal cutting temperature (OCT) compound (Sakura Finetek, Torrance, CA, USA) and stored at À80°C for subsequent immunofluorescence staining. The remaining penile tissues were snap-frozen in liquid nitrogen and stored at À80°C for subsequent ELISA.
Detection of IGF-1, bFGF, and VEGF levels in supernatants Passage 4 ADSCs were seeded in 10% FBS-supplemented DMEM medium in a 24-well dish. At 80% confluence, ADSCs were labeled with lipophilic fluorochrome chloromethylbenzamido dialkylcarbocyanine (CM-DiI, 5 lmol/mL; Molecular Probes) or PBS according to the manufacturer's instructions. Then, the culture medium was changed into serum-free DMEM medium. Basal medium was used as a control. After 24 h, conditioned medium was collected and centrifuged at 3000 g for 5 min. IGF-1, bFGF, and VEGF released from ADSCs were measured by an enzyme-linked immunosorbent assay (ELISA) kit (Shanghai Xitang Biotechnology Co., Ltd., Shanghai, China) according to the manufacturer's instructions.
Concentrations of IGF-1, bFGF, and VEGF in rat penile tissues IGF-1, bFGF, and VEGF concentrations in penile tissue homogenates were determined by an enzyme-linked immunosorbent assay (ELISA) kit (Shanghai Xitang Biotechnology Co., Ltd.) according to the manufacturer's instructions.
Isolation and culture of rat corpus cavernosum smooth muscle cells in vitro (CCSMCs)
In our previous study, we successfully isolated and cultured CCSMCs in vitro . Briefly, corpus cavernosum tissues were obtained from 8-week-old rats. They were minced into cubes of approximately 1 mm 3 in size and placed in an overturned 25-cm 2 culture flask, followed by the addition of a small amount of low-glucose DMEM (Thermo Fisher, Waltham, MA, USA). The overturned flask was placed in a humidified 5% CO 2 , 95% air incubator at 37°C for 30 min. Then, the flask was turned upright and the tissues were submerged in culture medium. CCSMCs migrating from the explants were purified by differential adherence velocity. We cultured CCSMCs as follows: under regular conditions (DMED+10% FBS) as the control group; in conditioned medium (CM, in this study, CM always refers to conditioned medium) under the conditions of oxidative stress (CM+200 lmol/L H 2 O 2 ); in CM plus neutralizing antibody for the three growth factors (IGF-1/bFGF/VEGF) (Merck Millipore, Darmstadt, Germany) separately or combined under the conditions of oxidative stress (CM+200 lmol/L H 2 O 2 +IGF-1/bFGF/VEGF-neutralizing antibody); in a co-culture system with basic medium (BM) without FBS; and in a co-culture system with BM plus neutralizing antibodies of the three growth factors (IGF-1/bFGF/VEGF) separately or combined under the conditions of oxidative stress (BM+200 lmol/L H 2 O 2 +IGF-1/bFGF/VEGF-neutralizing antibody). After 48 h, we estimated the area covered by all cells, and cultures were stained with crystal violet according to the manufacturer's protocol (Sigma-Aldrich, St. Louis, MO, USA). We detected the proliferation of CCSMCs in the co-culture system via immunofluorescence staining.
The model of ADSCs co-cultured with CCSMCs is shown in Fig. 6a . ADSCs were seeded on Millicell and co-cultured with CCSMCs in 12-well plates. Millicell plates have a 0.4-lm-pore polycarbonate membrane, allowing the free exchange of proteins in the medium while preventing cell migration between the two compartments.
Preparation of CM
ADSCs were cultured as a monolayer in BM without FBS for 2 days, and then the CM was collected and centrifuged. The maximal cell densities were 3 9 10 5 cells/mL for the monolayer culture. We used three different batches to collect the CM for our experiments. At least three independent cell cultures were performed to collect the CM.
Immunofluorescence staining
Passage 4 ADSCs were fixed with 4% paraformaldehyde for 15 min at room temperature after labeling with CM-DiI (5 lmol/mL; Molecular Probes, Carlsbad, CA, USA). The cells were stained with DAPI (4',6-diamino-2-phenylindole; SigmaAldrich, St. Louis, MO, USA) to visualize all nuclei.
After 48-h co-culture, the CCSMCs were fixed in cold methanol for 5 min at 4°C, permeabilized with 0.05% Triton X-100 for 5 min, and blocked with 5% normal equine serum in PBS for 1 h at room temperature. The cells were then incubated with a-SMA (1 : 500; Abcam, Cambridge, MA, USA). The cells were stained with DAPI to visualize all cell nuclei.
The erectile tissues were cut transversely at 8 lm and adhered to slides, which were blocked with 3% bovine serum in PBS with 0.01% Triton X-100 for 30 min at room temperature. After draining the excess fluid, sections were incubated at 4°C overnight with a primary antibody against Desmin (1 : 500; Abcam) or vWF (1 : 500; Abcam).
Secondary detection was performed with fluorescein isothiocyanate (FITC)-conjugated secondary antibody (1 : 5000) for 1 h at room temperature. DAPI was used to visualize all cell nuclei. Fluorescence images were acquired using an Olympus BX51 fluorescence microscope (Olympus Corporation, Tokyo, Japan) and were further quantified using IMAGE-PRO PLUS software (Media Cybernetics Inc., Bethesda, MD, USA).
Examination of antioxidant activity
Penile tissues were stored at À80°C for assaying antioxidant activity. Commercial assay kits for measuring malondialdehyde (MDA, S0131; Beyotime Institute of Biotechnology, Shanghai, China) and superoxide dismutase (SOD, S0101; Beyotime Institute of Biotechnology) were obtained from Beyotime Institute of Biotechnology and used according to the manufacturer's instructions. Penile MDA level and SOD activities were normalized to the wet weight of penile tissues.
Statistical analysis
The Shapiro-Wilk test was used to evaluate whether data were normally distributed. All data met the assumptions of normality and are expressed as the mean AE standard deviation (SD). Statistical analyses were performed by one-way ANOVA test with the Bonferroni multiple comparison post-test using the Statistical Package for the Social Sciences (SPSS), version 12.0 for WINDOWS (SPSS Inc., Chicago, IL, USA). p-values < 0.05 indicate statistical significance.
RESULTS
Morphology and characterization of ADSCs
Passage 4 ADSCs predominantly expressed the mesenchymal stem cell (MSC) markers, CD29 and CD90 but were negative for 500 Andrology, 2018, 6, 498-509 CD31, CD34, CD45, and CD106 (Fig. 1a) , indicating the cells were ADSCs as reported previously (Ma et al., 2012) . Isolated ADSCs obtained from the inguinal adipose expanded rapidly in culture, and passage 4 ADSCs exhibited spindle-shaped morphology (Fig. 1b) . ADSCs differentiated into mature adipocytes identified by intracellular lipid droplets after Oil Red O staining (Fig. 1c) , and osteoblasts confirmed by matrix mineralization after Alizarin Red staining (Fig. 1d) .
CM-DiI labeling of ADSCs in vitro and IGF-1, bFGF, and VEGF levels in supernatants
Immunofluorescence staining analysis revealed that most ADSCs were positive for CM-DiI (red color) after labeling in vitro (Fig. 2a) , and as shown in Fig. 2b-d , ADSCs and CM-DiI labeled ADSCs secreted significantly greater amounts of IGF-1, bFGF, and VEGF into the culture medium compared with basal medium (p < 0.05 vs. basal medium). There was no difference between ADSCs and CM-DiI-labeled ADSCs, indicating CM-DiI labeling did not affect the secretion of IGF-1, bFGF, and VEGF. RT-PCR was done to figure out which growth factor elevated at least three times after serum free DMEM culture of ADSCs for 24 hours( Figure S1 ).
Effect of ADSC treatment on CCSMCs in vitro under the conditions of oxidative stress
In cell experiments, crystal violet staining showed a significant decrease in the area covered by cells in the CM+200 lmol/L H 2 O 2 + all three neutralizing antibody group, with no differences among the three groups when only one neutralizing antibody was used. However, the CM+200 lmol/L H 2 O 2 + all three neutralizing antibodies group showed a significant difference compared with other groups (p < 0.05 vs. other groups; Fig. 3a,b) . The CM+200 lmol/L H 2 O 2 group showed no obvious decrease in the area covered by cells compared with the control group. Immunofluorescence staining of CCSMCs in a co-culture system demonstrated a significant decrease of cell proliferation in the BM+200 lmol/L H 2 O 2 +IGF-1/bFGF/VEGF-neutralizing antibody group, with no differences among the three groups when one neutralizing antibody was used. We also found the BM+200 lmol/L H 2 O 2 + all three neutralizing antibodies group showed a significant difference compared with the BM+200 lmol/L H 2 O 2 +VEGF Ab group (p < 0.05 vs. other groups; Fig. 3d,e) , but no differences compared with the BM+200 lmol/L H 2 O 2 +IGF-1/bFGF Ab group. Similarly, the BM+200 lmol/L H 2 O 2 group showed no differences with the control group. We also observed the protective effect of conditioned DMEM didn't diminish even after 7 days ( Figure S2 ).
Effect of ADSC treatment on erectile responses
Electrical stimulation of the cavernous nerve was performed to evaluate erectile function. Compared with young rats, untreated aged rats had significantly (p < 0.05) lower Max ICP/ MAP at 2.5, 5.0, and 7.5 V, respectively. At 2 weeks after the intracavernous injection of ADSCs, aged rats showed significantly increased Max ICP/MAP at all stimulation voltages (all p < 0.05 vs. untreated aged rats; Fig. 4 ).
Transplanted ADSCs in the corpus cavernosum
There was only a small number of CM-DiI-labeled ADSCs (red color area/blue color area, 0.04364 AE 0.0103) in the corpus cavernosum of ADSCs-treated aged rats at 2 weeks after intracavernous transplantation (Fig. 5a ).
Effect of ADSC treatment on concentrations of IGF-1 and VEGF in rat penile tissues
Compared with young rats, the concentrations of IGF-1, bFGF, and VEGF were significantly (p < 0.05) decreased in untreated aged rat penile tissues, which was confirmed by ELISA. The intracavernous administration of ADSCs increased cavernous IGF-1, bFGF, and VEGF concentrations in the penile tissues of ADSCtreated aged rats (p < 0.05 vs. untreated aged rats; Fig. 5b-d) .
Treatment of ADSCs inhibits oxidative stress in CC of aged rats
We detected the oxidative stress levels in all the three groups. The untreated aged group showed a lower SOD activity and a higher MDA level compared with the other two groups, while the change in the SOD activity and MDA level was partly, but significantly diminished in the ADSC-treated aged rats group (both p < 0.05; Fig. 6a,b) .
Effect of ADSC treatment on the contents of cavernous smooth muscle and endothelium
Immunofluorescence staining of penile tissues from young and untreated aged rats demonstrated a significant decrease in the contents of cavernous smooth muscle and endothelium that were associated with aging. The transplantation of ADSCs Figure 2 CM-DiI labeling of ADSCs in vitro and IGF-1, bFGF, and VEGF levels in ADSC-conditioned medium. (a) In vitro immunofluorescence staining shows most ADSCs were stained red (positive for CM-DiI), and all nuclei were stained blue after labeling (magnification: 9100). (b, c, d) ADSCs and CMDiI-labeled ADSCs secreted a large amount of IGF-1, bFGF, and VEGF in supernatants after 24 h in serum-free DMEM medium. Data are expressed as the mean AE SD (n = 3/group). *p < 0.05 vs. DMEM medium group. IGF-1-insulin-like growth factor-1; bFGF-basic fibroblast growth factor; VEGF-vascular endothelial growth factor; ADSCs-adipose-derived stem cells; CM-DiI-chloromethylbenzamido dialkylcarbocyanine; DMEM-Dulbecco's modified Eagle's medium. 
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increased the contents of cavernous smooth muscle and endothelium in ADSC-treated aged rats (p < 0.05 vs. untreated aged rats; Fig. 7 ). The results of Masson's staining also showed similar trends ( Figure S3 ).
DISCUSSION
This study revealed that the intracavernous injection of ADSCs significantly improved electrically induced erectile function in aged rats. It was confirmed that ADSCs secreted a large amount of IGF-1, bFGF, and VEGF through paracrine actions in vitro. Furthermore, the intracavernous administration of ADSCs increased the concentrations of IGF-1, bFGF, and VEGF in penile tissues, which were partially responsible for the increased content of cavernous smooth muscle and endothelium, and improved erectile function in aged rats. Thus, the transplantation of ADSCs appeared to be an effective treatment for resolving aging-related ED through the secretion of IGF-1, bFGF, and VEGF in this rat model.
Penile erection is a complex process including arterial dilation, relaxation of the cavernous smooth muscle, and the veno-occlusive activation (Gratzke et al., 2010) . Normal erectile function of penile is also dependent on normal structure and function of penile components, such as endothelium, smooth muscle, nerves, and so on. Any factors disturbing the processes of erectile or impairing normal penile components may lead to ED. However, as men age, it is observed that an aging-dependent decrease of the functioning cavernous smooth muscle occurred. Besides, decreased levels of testosterone, oxidative stress, fibrosis, and apoptosis of cavernous smooth muscle are also major causes of age-related ED (Ferrini et al., 2017) . In recent years, 504 Andrology, 2018, 6, 498-509 many researchers tried to use various kinds of stem cells to improve erectile function of aged rats (Bivalacqua et al., 2007; Nolazco et al., 2008; Abdel et al., 2010) .
Veno-occlusive dysfunction caused by decreased cavernous smooth muscle content and increased collagen deposition is one of the main mechanisms of aging-related ED (Nolazco et al., 2008; Chung et al., 2011) . A study by Bivalacqua et al. showed that the intracavernous administration of unmodified BMSCs or endothelial nitric oxide synthase (eNOS)-modified BMSCs restored aging-related ED 21 days after injection (Bivalacqua et al., 2007) and that lacZ-labeled BMSCs differentiated into smooth muscle and endothelial cells in the corpus cavernosum, which was partially responsible for the beneficial effect of improved erectile function (Bivalacqua et al., 2007) . Furthermore, Nolazco et al. demonstrated that DAPI-labeled MDSCs converted into smooth muscle cells in corporal tissues and corrected aging-related ED 4 weeks after intracavernous injection (Nolazco et al., 2008) .
However, the concept that the incorporation of stem cells in the corpus cavernosum contributes to the beneficial effect of enhancing erectile function remains controversial (Hakim et al., 2012) . In contrast with the studies mentioned above, many Figure 5 ADSCs in corpus cavernosum of aged rats after 2 weeks of treatment with ADSCs. (a) Immunofluorescence staining shows representative images of CM-DiI-labeled ADSCs (red) and nuclei (blue) in the corpus cavernosum of aged rats after 2 weeks of treatment with ADSCs (magnification: 9200). CMDiI-chloromethylbenzamido dialkylcarbocyanine; ADSCs-adipose-derived stem cells. (b, c, d ) Cavernous IGF-1, bFGF, and VEGF concentrations were determined by ELISA. Data in the bar graphs indicate the mean AE SD (n = 7-8 rats/group). *p < 0.05 vs. young rats group. #p < 0.05 vs. untreated aged rats group. IGF-1-insulin-like growth factor-1; bFGF-basic fibroblast growth factor; VEGF-vascular endothelial growth factor; ADSCs-adipose-derived stem cells; CM-DiI-chloromethylbenzamido dialkylcarbocyanine. [Colour figure can be viewed at wileyonlinelibrary.com] Figure 6 Treatment of ADSCs inhibits oxidative stress in corpus cavernous of aged rats. (a) MDA levels determined by the ELISA method in all the three groups. (d) SOD activities determined by the ELISA method in all the three groups. Data are expressed as mean AE SD (n = 3-4). *p < 0.05 when comparing young rats. #p < 0.05 when comparing aged rats. ADSCs-adipose-derived stem cells. ELISA-enzyme-linked immunosorbent assay; SOD-superoxide dismutase; MDA-malondialdehyde.
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researchers support the idea that a paracrine action rather than the differentiation of stems cells has a major role in the efficacy of therapeutic stem cell treatment (Albersen et al., 2010; Garcia et al., 2010; Huang et al., 2010; Zhang et al., 2011; Fandel et al., 2012; Nishimatsu et al., 2012) . Carcia et al. showed that thymidine analog bromodeoxyuridine (BrdU)-labeled ADSCs increased erectile function 21 days after injection but no significant incorporation of cells was observed in type 2 diabetes rats (Garcia et al., 2010) . Huang et al., (2010) reported that 5-ethynyl-2'-deoxyuridine (EdU)-labeled ADSCs enhanced erectile function 4 weeks after injection but low staining for EdU was found in rats with hyperlipidemia. Nishimatsu et al., (2012) demonstrated that PKH26-labeled ADSCs restored erectile function mainly through producing adrenomedullin 4 weeks after injection in rats with type 1 diabetes. In the cavernous nerve crush model, several researchers speculated that ADSCs improved erectile function mainly through paracrine action rather than cell differentiation (Albersen et al., 2010; Zhang et al., 2011; Fandel et al., 2012) . Here, we demonstrated that the contents of the cavernous smooth muscle and endothelium were significantly increased and that erectile function was dramatically enhanced in aged rats 2 weeks after the intracavernous injection of ADSCs. ADSCs were labeled with CM-DiI, and CM-DiL was one of DiI derivatives and had the ability for long-term cellular labeling but exerted almost no influence on cell function. Because the number of CM-DiI-positive ADSCs was very small in corporal tissues 2 weeks after injection, we presumed that the improved erectile function was mediated by the paracrine effects of ADSCs.
IGF-1 is a single-chain polypeptide and a member of the insulin gene family. It regulates the proliferation and differentiation of a number of cell types by activating the type 1 insulin-like growth factor receptor (IGF-1R). The decreased expression of IGF-1 in corporal tissues was associated with ED (Pu et al., 2007 (Pu et al., , 2008 Castela et al., 2012) . Bochinski et al., (2004) demonstrated that the intraperitoneal injection of IGF-1 enhanced erectile function by facilitating the regeneration of nitric oxide synthase (NOS)-containing fibers in a rat model of bilateral cavernous nerve cryoablation. Pu and colleagues have extensively studied IGF-1 therapy for ED treatment. They found that gene transfer of IGF-1 and injection of IGF-1 protein restored erectile function in diabetic rats and aged rats, respectively (Pu et al., 2007 (Pu et al., , 2008 . In the latter study, they found that both 1 and 10 lg/kg IGF-1 treatment improved erectile function 4 and 8 weeks after a single injection. Furthermore, the mechanism for this beneficial effect was the restoration of cavernous smooth muscle content and activation of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway (Pu et al., 2007) . (c, d) The contents of the cavernous smooth muscle and endothelium are defined as a-SMA area/Total area and vWF/Total area, respectively. Data in the bar graphs indicate the mean AE SD (n = 6-8 rats/group). *p < 0.05 vs. young rats group. #p < 0.05 vs. untreated aged rats group. ADSCs-adipose-derived stem cells. vWFvon Willebrand factor; DAPI-4',6-diamino-2-phenylindole. [Colour figure can be viewed at wileyonlinelibrary.com] 506 Andrology, 2018, 6, 498-509 bFGF is a member of the fibroblast growth factor family, which plays a significant role in the pathogenesis of several diseases including osteogenesis, adipogenesis, and normal wound healing, by inducing angiogenesis (Tabata, 2003) . It was reported that bFGF treatment ameliorated erectile function in animal models (Suetomi et al., 2005; Bae et al., 2014; Lee et al., 2014) . Takahiro et al. reported that bFGF-incorporating gelatin microspheres were effective for the preservation of erectile function and corporeal smooth muscles in a diabetic animal model (Suetomi et al., 2005) . Similarly, Jang and colleagues compared an injection of bFGF-hydrogel into both sides of the penile subcutaneous ring site with ADSC injection into the corpus cavernosum. After 4 weeks, they found that these two methods had a similar effect on improving erectile function (Bae et al., 2014) .
VEGF is a chemical signal protein produced by cells that play an important role in vasculogenesis and angiogenesis. Various studies have found that the expression of VEGF is decreased in the penile tissues of rats or humans with ED indicating VEGF is a promising target for the treatment of ED by enhancing the proliferation of cavernous smooth muscle cells and endothelial cells (Liu et al., 2001; Rajasekaran et al., 2002; Park et al., 2004; Ryu et al., 2006; Tomada et al., 2010; Gou et al., 2011; Qiu et al., 2012) . Rajasekaran et al., (2002) showed that the expression of VEGF was significantly decreased in the erectile tissues of aged rats, which contributed to the abnormal age-related morphological and physiological alterations. Furthermore, Park et al., (2004) explored the effectiveness of intracavernosal injections of VEGF on erectile function in aged rats. They found that compared with the vehicle-only group, the erectile response to neurostimulation was dramatically improved after 1 and 10 lg/kg VEGF treatment at 4 weeks of intracavernosal injection. The main mechanism for the improvement of erectile function in aged rats was the restoration of the cavernous smooth muscle integrity (Park et al., 2004) .
Many basic research studies have established that oxidative stress has an important role in the pathophysiological process of erectile dysfunction. The mechanisms may correlate with lipid peroxidation, protein oxidation, DNA oxidation, decreased synthesis, and bioavailability of nitric oxide (NO) (Barassi et al., 2009) . Some growth factors were shown to prevent cell dysfunction caused by oxidative stress. Chen et al., (2014) genetically engineered rat muscle-derived stem cells (MDSCs) to overexpress IGF-1 and found they prevented H 2 O 2 -induced caspasedependent apoptosis cell death and had enhanced paracrine functions under oxidative stress. Daria et al. isolated mesenchymal stromal cells that reside in adipose tissues (ASCs) and demonstrated cell exposure to 5 or 10 ng/mL bFGF increased proliferative activity, reduced cellular senescence, and decreased oxidative stress. Furthermore, the suppression of oxidative stress by bFGF correlated with decreased transcript levels of p21 and p53 genes in bFGF-treated diabetic ASCs (Nawrocka et al., 2017) . Similarly, Hao et al. reported that VEGF had a neuroprotective role under oxidative stress conditions through VEGF signaling especially via VEGFR-2 (Hao & Rockwell, 2013) .
We investigated whether the growth factors IGF-1, bFGF, and VEGF secreted by ADSCs were associated with improved erectile function in aged rats. We found that passage 4 ADSCs secreted IGF-1, bFGF, and VEGF via paracrine action in vitro. Furthermore, 2 weeks after the intracavernous administration of ADSCs, the concentrations of IGF-1, bFGF, and VEGF were significantly increased in penile tissues and were confirmed by ELISA. And the MDA level of corpus cavernous became higher while the activity of SOD became lower, which indicated the changes of oxidative stress. The contents of the corporal smooth muscle and endothelium were also dramatically increased, which was confirmed by immunofluorescence staining. Furthermore, in vitro experiments especially using a co-culture system indicated that the three growth factors prevented cell dysfunction separately from exposure to H 2 O 2 , which was used to simulate oxidative stress. Interestingly, IGF-1, bFGF, and VEGF had synergistic effects in protecting cell proliferation. Therefore, the improved erectile function was at least partially mediated by increased IGF-1, bFGF, and VEGF concentrations secreted by ADSCs.
Apart from a broad spectrum of paracrine factors, ADSCs produce exert protective effect on ED, and abundant particles called exosomes (EXOs) secreted by ADSCs also play an ameliorative role in ED. Chen et al. cultured ADSCs in vitro and isolated EXOs from the supernatants of ADSCs through ultracentrifugation; then, ADSCs-derived EXOs and ADSCs were applied to an ED rat model of type 2 diabetes mellitus. They found that not only ADSCs but also ADSCs-derived EXOs could partly restore erectile function of diabetic rats by suppressing the apoptosis of corpus cavernosum smooth muscle and endothelial cells (Chen et al., 2017) . Zhu et al., (2018) also demonstrated that ADSCs-derived EXOs show proangiogenic properties via inducing the proliferation of endothelial cells in vitro and therapeutical effect on diabetic ED through decreasing fibrosis. It is further revealed that cell-free therapy has great potential in the treatment of ED and more attention should be paid on the relationship between ADSCs-derived EXOs and ED.
However, in this study, it is limited that we only focused on IGF-1, bFGF, and VEGF because of their important roles in erectile function. Exploring other growth factors and identifying which are most effective will be performed in our future studies.
CONCLUSION
ADSCs secreted IGF-1, bFGF, and VEGF through paracrine action and increased the contents of the cavernous smooth muscles and endothelium in the penile tissues of aged rats. The three growth factors ameliorated the function of CCSMC proliferation under oxidative stress. Finally, these molecular changes accompanied a significant enhancement of erectile function. The findings provide evidence that ADSCs may relieve aging-related ED partially through the secretion of IGF-1, bFGF, and VEGF. corrected the manuscript. JHL and ZT guided the experimental direction and drafted the manuscript. All authors read and approved the final manuscript.
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Additional Supporting Information may be found in the online version of this article: Figure S1 . Real-time RT-PCR analysis of cytokines. HGF, ANG-1, IGF-1, VEGF, bFGF met the criterion (at least three-times). Figure S2 . Effects of ADSCs on histologic changes of penile tissues. Figure S3 . Protective effect of IGF-1, VEGF and bFGF on CCSMCs and endothelial cells.
